129 related articles for article (PubMed ID: 15755607)
1. Peptide-based candidate vaccine against respiratory syncytial virus.
Yusibov V; Mett V; Mett V; Davidson C; Musiychuk K; Gilliam S; Farese A; Macvittie T; Mann D
Vaccine; 2005 Mar; 23(17-18):2261-5. PubMed ID: 15755607
[TBL] [Abstract][Full Text] [Related]
2. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
[TBL] [Abstract][Full Text] [Related]
3. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
[TBL] [Abstract][Full Text] [Related]
4. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology.
de Waal L; Wyatt LS; Yüksel S; van Amerongen G; Moss B; Niesters HG; Osterhaus AD; de Swart RL
Vaccine; 2004 Feb; 22(8):923-6. PubMed ID: 15161069
[TBL] [Abstract][Full Text] [Related]
6. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
Johnson JE; McNeil LK; Megati S; Witko SE; Roopchand VS; Obregon JH; Illenberger DM; Kotash CS; Nowak RM; Braunstein E; Yurgelonis I; Jansen KU; Kalyan NK; Sidhu MK
Immunol Lett; 2013 Feb; 150(1-2):134-44. PubMed ID: 23261719
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
8. Human respiratory syncytial virus vaccine antigen produced in plants.
Belanger H; Fleysh N; Cox S; Bartman G; Deka D; Trudel M; Koprowski H; Yusibov V
FASEB J; 2000 Nov; 14(14):2323-8. PubMed ID: 11053254
[TBL] [Abstract][Full Text] [Related]
9. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
Huang Y; Cyr SL; Burt DS; Anderson R
J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
[TBL] [Abstract][Full Text] [Related]
10. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge.
de Waal L; Power UF; Yüksel S; van Amerongen G; Nguyen TN; Niesters HG; de Swart RL; Osterhaus AD
Vaccine; 2004 Feb; 22(8):915-22. PubMed ID: 15161068
[TBL] [Abstract][Full Text] [Related]
12. Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination.
Helson R; Olszewska W; Singh M; Megede JZ; Melero JA; O'Hagan D; Openshaw PJ
Vaccine; 2008 Feb; 26(6):753-61. PubMed ID: 18191308
[TBL] [Abstract][Full Text] [Related]
13. Fusion of DsbA to the N-terminus of CTL chimeric epitope, F/M2:81-95, of respiratory syncytial virus prolongs protein- and virus-specific CTL responses in Balb/c mice.
Fan CF; Zeng RH; Sun CY; Mei XG; Wang YF; Liu Y
Vaccine; 2005 Apr; 23(22):2869-75. PubMed ID: 15780735
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus: reverse genetics and vaccine strategies.
Collins PL; Murphy BR
Virology; 2002 May; 296(2):204-11. PubMed ID: 12069519
[No Abstract] [Full Text] [Related]
15. A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.
Langley JM; Sales V; McGeer A; Guasparini R; Predy G; Meekison W; Li M; Capellan J; Wang E
Vaccine; 2009 Sep; 27(42):5913-9. PubMed ID: 19651171
[TBL] [Abstract][Full Text] [Related]
16. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus.
Steward MW
Biologicals; 2001; 29(3-4):215-9. PubMed ID: 11851318
[TBL] [Abstract][Full Text] [Related]
17. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
[TBL] [Abstract][Full Text] [Related]
19. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
Voges B; Vallbracht S; Zimmer G; Bossow S; Neubert WJ; Richter K; Hobeika E; Herrler G; Ehl S
Cell Immunol; 2007 Jun; 247(2):85-94. PubMed ID: 17904538
[TBL] [Abstract][Full Text] [Related]
20. DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys.
Vaughan K; Rhodes GH; Gershwin LJ
Vaccine; 2005 Apr; 23(22):2928-42. PubMed ID: 15780742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
